Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
Business Wire India Data from Phase 3 MANEUVER study demonstrating significant improvements in physical function and symptoms in patients with tenosynovial giant cell tumor (TGCT) treated with pimicotinib, to be…